It turns out that you can trust gay men at high risk for HIV to take care of their health -- even if they have to remember to take an HIV prevention pill before sex.
Janssen Vaccines and Prevention B.V. is now rapidly advancing an experimental prime-boost HIV vaccine regimen, with plans announced to launch a large-scale "proof of concept" efficacy trial in women in late 2017/early 2018.
Brief IAS 2017 summaries of ongoing research on pre-exposure prophylaxis (PrEP), evaluating its long-term effectiveness and safety, patient experiences, and alternative dosing schedules, such as an on-demand regimen.
The vaccine candidate is called a "mosaic" vaccine because it includes snippets from a variety of different HIV subtypes, called clades. It is designed to work globally against most clades.
A vaginal ring that contains dapivirine was "liked" by 93% of adolescent participants in a small U.S. trial of the device that was presented at IAS 2017.
Dapivirine does not appear to be affected by a woman's vaginal microbiome composition when administered as a vaginal gel or film.
Cows injected with proteins mimicking HIV were able to rapidly produce broadly neutralizing antibodies in their blood as soon as 35 days after immunization, according to a new study.
Swaziland has dramatically reduced the number of new HIV infections while simultaneously getting a substantial portion of the HIV-positive population on treatment.
"There is good news and bad news, often in the same story," AVAC writes.
Tentative results suggest that a new approach to phylogenetic testing might have the potential to show the direction of HIV infection between two individuals.